Critsal Forte Rota Cap is a dual-action respiratory formulation combining Levosalbutamol 100 mcg and Beclometasone 200 mcg, offering both quick bronchodilation and long-lasting anti-inflammatory control. It is designed to help patients breathe easier, reducing episodes of wheezing, chest tightness, and airway obstruction. Its rapid-action bronchodilator helps open the air passages instantly for quick relief.
The addition of Beclometasone provides deep anti-inflammatory action, decreasing swelling and irritation inside the airways. This makes the product ideal not only for acute symptoms but also for long-term respiratory maintenance. Clinicians rely on this combination for patients with asthma, reactive airway diseases, and chronic breathing issues requiring regular management.
For distributors and wholesalers, Critsal Forte Rota Cap is a high-volume respiratory product with consistent, year-round demand. Respiratory issues rise with pollution, seasonal changes, and urban lifestyles, making this formulation a fast-moving and widely prescribed option. Pharmacies, clinics, and hospitals regularly require stock, ensuring strong repeat orders.
Including Critsal Forte Rota Cap in your portfolio boosts your respiratory therapy segment and enhances business opportunities across franchise distribution, bulk orders, institutional supply, tender participation, and export networks. Its strong clinical relevance and high consumer requirement make it a profitable and strategic addition for any pharma distributor.